AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 91 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,555 | +23.3% | 11,013 | -1.1% | 0.00% | – |
| Q2 2023 | $10,185 | +48.2% | 11,131 | -9.2% | 0.00% | – |
| Q1 2023 | $6,873 | -11.6% | 12,264 | -9.0% | 0.00% | – |
| Q4 2022 | $7,778 | +94.4% | 13,479 | -2.4% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 13,814 | -7.6% | 0.00% | – |
| Q2 2022 | $4,000 | -98.1% | 14,956 | -94.9% | 0.00% | – |
| Q1 2022 | $212,000 | -73.1% | 295,633 | -15.0% | 0.00% | – |
| Q4 2021 | $787,000 | +86.9% | 347,953 | +138.6% | 0.00% | – |
| Q3 2021 | $421,000 | +461.3% | 145,810 | +642.0% | 0.00% | – |
| Q2 2021 | $75,000 | -79.6% | 19,651 | -81.9% | 0.00% | – |
| Q1 2021 | $367,000 | -49.7% | 108,395 | -58.4% | 0.00% | – |
| Q4 2020 | $730,000 | -6.6% | 260,706 | -16.4% | 0.00% | – |
| Q3 2020 | $782,000 | -81.2% | 311,890 | +1.8% | 0.00% | -100.0% |
| Q2 2020 | $4,160,000 | +126.5% | 306,323 | +26.4% | 0.00% | 0.0% |
| Q1 2020 | $1,837,000 | +44.0% | 242,353 | +20.1% | 0.00% | – |
| Q4 2019 | $1,276,000 | +59.9% | 201,843 | -1.0% | 0.00% | – |
| Q3 2019 | $798,000 | -2.7% | 203,787 | +20.3% | 0.00% | – |
| Q2 2019 | $820,000 | -32.7% | 169,395 | +13.8% | 0.00% | – |
| Q1 2019 | $1,218,000 | +38.7% | 148,829 | -6.2% | 0.00% | – |
| Q4 2018 | $878,000 | +26.5% | 158,610 | +101.7% | 0.00% | – |
| Q3 2018 | $694,000 | -41.9% | 78,637 | -34.3% | 0.00% | – |
| Q2 2018 | $1,194,000 | +9.7% | 119,685 | +4.8% | 0.00% | – |
| Q1 2018 | $1,088,000 | -39.6% | 114,178 | -5.8% | 0.00% | -100.0% |
| Q4 2017 | $1,802,000 | +2.7% | 121,212 | +35.9% | 0.00% | 0.0% |
| Q3 2017 | $1,754,000 | +38.5% | 89,188 | +1.2% | 0.00% | – |
| Q2 2017 | $1,266,000 | +57.9% | 88,116 | +1.0% | 0.00% | – |
| Q1 2017 | $802,000 | -13.4% | 87,236 | -2.0% | 0.00% | – |
| Q4 2016 | $926,000 | +21.7% | 89,047 | +5.9% | 0.00% | – |
| Q3 2016 | $761,000 | +22.5% | 84,075 | +1.1% | 0.00% | – |
| Q2 2016 | $621,000 | -20.8% | 83,123 | -4.5% | 0.00% | – |
| Q1 2016 | $784,000 | -34.1% | 87,057 | -5.5% | 0.00% | – |
| Q4 2015 | $1,190,000 | +829.7% | 92,151 | +592.3% | 0.00% | – |
| Q3 2015 | $128,000 | +52.4% | 13,310 | +63.9% | 0.00% | – |
| Q2 2015 | $84,000 | -53.8% | 8,121 | -50.0% | 0.00% | – |
| Q1 2015 | $182,000 | +127.5% | 16,226 | +133.0% | 0.00% | – |
| Q4 2014 | $80,000 | +175.9% | 6,963 | +431.5% | 0.00% | – |
| Q3 2014 | $29,000 | -69.8% | 1,310 | -62.1% | 0.00% | – |
| Q2 2014 | $96,000 | – | 3,457 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |